Answers are grounded in this paper and cite their sources.
This study demonstrates that CLEC3B acts as a novel independent prognostic factor, and CLEC3B in exosomes might be a potential therapeutic target for hepatocellular carcinoma.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: